Skip to main content

Nasdaq IPOs

Viral disease biotech AlloVir sets terms for $251 million IPO

6 years 2 months ago
AlloVir, a Phase 2 biotech developing allogeneic T cell therapies for viral diseases, announced terms for its IPO on Thursday. The Cambridge, MA-based company plans to raise $251 million by offering 14.8 million shares at a price range of $16 to $18. At the midpoint of the propos
Renaissance Capital

Chinese micro-cap Skillful Craftsman prices US IPO at $5 midpoint

6 years 2 months ago
Skillful Craftsman Education Technology, which provides online education and technology services in China, raised $15 million by offering 3 million shares at $5, the midpoint of the range of $4.50 to $5.50. At pricing, the company commands a market value of $62 million. Skillful
Renaissance Capital

Energy SPAC East Resources Acquisition prices $300 million IPO at $10

6 years 2 months ago
East Resources Acquisition, a blank check company formed by Terrence Pegula targeting the North American energy industry, raised $300 million by offering 30 million units at $10. Each unit consists of one share of common stock and one-half of a warrant, exercisable at $11.50.&nbs
Renaissance Capital

Wound treatment device maker ACell postpones $75 million IPO

6 years 2 months ago
ACell, which makes surgical soft tissue implants for wounds and hernia repair, postponed its IPO on Monday. It had filed to raise $75 million by offering 5 million shares at a price range of $14 to $16. The Columbia, MD-based company was founded in 1999 and booked $100 million in
Renaissance Capital
Checked
27 minutes 49 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed